Skip to main content

Table 3 Univariate and multivariable logistic regression models for the prediction of gBRCA mutations in patients with breast cancer

From: Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer

Variables

Univariate

 

Multivariate

OR (95% CI)

p

 

OR (95% CI)

p

Age at diagnosis

0.98 (0.95, 1.00)

0.093

 

0.97 (0.94, 0.99)

0.021*

Tumor size

1.00 (0.98, 1.03)

0.687

   

Menopausal status

0.95 (0.52, 1.69)

0.870

   

Multiple lesions

0.62 (0.24, 1.37)

0.264

   

Bilateral breast cancer

1.68 (0.80, 3.38)

0.158

 

1.13 (0.36, 3.32)

0.826

Personal history of breast cancer

2.31 (0.81, 6.22)

0.101

 

3.38 (0.76, 15.23)

0.108

Personal history of other BRCA-related cancers

16.65 (2.63, 321.40)

0.011*

 

48.10 (5.51, 1143.00)

0.002*

Family history of breast cancer

3.37 (1.98, 5.73)

 < 0.001*

 

4.44 (2.47, 8.09)

 < 0.001*

Family history of other BRCA-related cancers

1.33 (0.41, 3.70)

0.603

   

Histological subtype

4.65 (0.91, 84.87)

0.141

 

4.46 (0.72, 88.37)

0.182

Grade

1.04 (0.64, 1.70)

0.883

   

Lymph node status

0.93 (0.57, 1.52)

0.762

   

ER status

1.71 (1.02, 2.85)

0.039*

 

1.59 (0.90, 2.82)

0.112

PR status

1.00 (0.60, 1.64)

0.986

   

Ki67

3.06 (1.18, 10.46)

0.040*

 

3.60 (1.14, 16.20)

0.051

HER-2 status

2.00 (1.05, 4.08)

0.043*

 

2.15 (1.08, 4.61)

0.038*

  1. BRCA Breast cancer susceptibility gene, ER Estrogen receptor, PR Progesterone receptor, HER-2 Human epidermal growth factor receptor 2
  2. *Significance at p < 0.050